~ 235 ~ The Pharma Innovation Journal 2018; 7(12): 235-237 ISSN (E): 2277- 7695 ISSN (P): 2349-8242 NAAS Rating: 5.03 TPI 2018; 7(12): 235-237 © 2018 TPI www.thepharmajournal.com Received: 14-10-2018 Accepted: 15-11-2018 Sazid Alam PG Scholars, Dept. of Moalajat, LUMCH & Research Centre, Bijapur, Karnataka, India Md. Anzar Alam Ph D Scholar, Dept. of Moalajat, NIUM, Bangalore, Karnataka, India Khalid Eqbal PG Scholars, Dept. of Moalajat, LUMCH & Research Centre, Bijapur, Karnataka, India Mohd Aleemuddin Quamri Reader, Dept of Moalajat, NIUM, Bangalore, Karnataka, India Ghulamuddin Sofi Reader, Dept of Ilmul Advia, NIUM, Bangalore, Karnataka, India Correspondence Sazid Alam PG Scholars, Dept. of Moalajat, LUMCH & Research Centre, Bijapur, Karnataka, India Approach of understanding dyslipidaemia in unani medicine Sazid Alam, Md. Anzar Alam, Khalid Eqbal, Mohd Aleemuddin Quamri and Ghulamuddin Sofi Abstract Dyslipidaemia is a common metabolic disorder which is a major cause of coronary heart disease. It affects both genders, but is more common among males. In India 25-30% of urban and 15-20% rural subjects are suffering from dyslipidaemia.Currently, various synthetic lipid lowering agents are being used, however, Long term use of these medicine may leads to various adverse effects like hepatotoxicity, dyspepsia, myopathy, bloating, constipation, renal dysfunction etc. present study indertakes the concept of dyslipidemia as understtod in Unani mdicinee. Keywords: Dyslipidaemia, unani medicine, obesity Introduction Dyslipidaemia is a disorder of lipoprotein metabolism, which includes over production or deficiency of lipoproteins or both. It can manifest as an elevation of plasma cholesterol, triglycerides, or both, or a low high density lipoprotein level or all three together that contributes to the development of atherosclerosis [1] . Dyslipidaemia is a major contributor to cardiovascular morbidity and mortality. Although awareness of the importance of the risk of dyslipidaemia has increased, however, its treatment has not improved accordingly. Even though the actual number of individuals receiving treatment has increased, the proportion of those who are treated but did not reach the recommended treatment goal is still disturbing [2] . Gupta R et al (2017) reported that Dyslipidaemia is the most important atherosclerotic risk factor. Recent studies have reported that high cholesterol is present in 25-30% of urban and 15–20% rural subjects. This prevalence is lower than high-income countries. The most common Dyslipidaemia in India are borderline high LDL cholesterol, low HDL cholesterol and high triglycerides. Studies have reported that over a 20-year period, total cholesterol, LDL cholesterol and triglyceride levels have increased among urban populations. Case-control studies have reported that there is significant association of coronary events with raised apolipoprotein B, total cholesterol, LDL cholesterol and non-HDL cholesterol and inverse association with high apolipoprotein A and HDL cholesterol. Prevalence of suspected familial hypercholesterolemia in urban subjects varies from 1:125 to 1:450. Only limited studies exist regarding lipid abnormalities in children. There is low awareness, treatment and control of hypercholesterolemia in India [3, 4, 5] . Rasheed et al (2014) reported that prevalence of Dyslipidaemia varies according to the age, sex, race, geographical conditions and association with other diseases. The age group of 30 to 40 years has tendency to high prevalence, but above 60 years it become markedly high. Men are more prone to dyslipidaemic than women; rural population has less prevalence then urban in India. The prevalence with other disease association is high i.e. diabetes, obesity, renal disease and liver disease etc [6] . Dyslipidaemia is anoutcome of shifting from rural to urban that leads to sedentary lifestyle so the prevalence of Dyslipidaemia is higher in urban than rural areas [7] . There are several risk factor associated with Dyslipidaemiaviz; diabetes, obesity, hypertension, hypothyroidism, sedentary life style, fatty/oily diets, excess alcohol intake, smoking [8] . Untreated dyslipidaemia leads to co-morbid symptoms (tiredness, dyspnoea, lethargy, loss of appetite, weight gain, PCOD) and complication (hypertension, hypothyroidism, infertility, PCOD, atherosclerosis, coronary artery disease, cardiovascular Death) [9] . In Classical Unani literature, there is a concept of Quwt-e-Tabaiyah, which provides the functions of Taghziya (nutrition), Namiya (growth) and Tanasuliya (reproduction) in the body,